Skip to main content
Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · IEX Real-Time Price · USD
11.63
-0.07 (-0.60%)
May 20, 2024, 9:56 AM EDT - Market open

Sage Therapeutics Revenue

Sage Therapeutics had revenue of $91.06M in the twelve months ending March 31, 2024, with 868.87% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.90M with 139.89% year-over-year growth. In the year 2023, Sage Therapeutics had annual revenue of $86.46M with 1,024.84% growth.

Revenue (ttm)
$91.06M
Revenue Growth
+868.87%
P/S Ratio
7.73
Revenue / Employee
$186,990
Employees
487
Market Cap
704.13M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.46M78.77M1,024.84%
Dec 31, 20227.69M1.38M21.85%
Dec 31, 20216.31M-1.11B-99.43%
Dec 31, 20201.11B1.11B16,123.06%
Dec 31, 20196.87M-83.41M-92.39%
Dec 31, 201890.27M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PACS Group 3.34B
The Pennant Group 575.34M
National Research 147.42M
AnaptysBio 22.96M
Autolus Therapeutics 10.50M
Stoke Therapeutics 7.85M
Lyell Immunopharma 68.00K
Revenue Rankings

SAGE News

More News